Login / Signup

Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.

Eric J MooreKathryn M Van AbelDavid M RoutmanChristine M LohseKatharine A R PriceMichelle Neben-WittichAshish V ChintakuntlawarDaniel L PriceJan L KasperbauerJoaquin J GarciaMichael L HinniSamir H PatelJeffrey R JanusRobert L FooteDan J Ma
Published in: Head & neck (2020)
Patients with HPV(+)OPSCC who undergo surgical resection and neck dissection and meet criteria for adjuvant therapy can undergo aggressive dose de-escalation of RT without increasing risk of progression locally, regionally or at distant sites.
Keyphrases
  • open label
  • lymph node
  • high grade
  • clinical trial
  • randomized controlled trial
  • double blind
  • free survival